Alexia B.
- Country
- Italy
- Department
- Unit of Oncology and Hematology
Research Overview
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
- Phase II Randomized Trial of Trabectedin Versus Gemcitabine in Metastatic or Locally Advanced Leiomyosarcoma Post-Anthracycline Chemotherapy
Data & Insights
Has run more than one trial at 51 of 145 partner sites.
Specializations
Sarcoma Research
This investigator specializes in the treatment of leiomyosarcoma, with particular focus on advanced and metastatic cases. Their research encompasses both localized and systemic therapeutic approaches for patients with progressive disease.
- Metastatic leiomyosarcoma management
- Advanced sarcoma treatments
- Multi-line therapy strategies
The investigator evaluates novel therapeutic combinations and treatment sequences for improved patient outcomes in sarcoma care.
Neuroendocrine Tumors
The investigator conducts research in gastroenteropancreatic neuroendocrine tumors (GEP-NET), focusing on innovative treatment approaches for unresectable and metastatic cases.
- GEP-NET therapeutic management
- Advanced neuroendocrine tumor treatment
- Long-acting therapeutic applications
Their work explores new therapeutic options for patients with progressive neuroendocrine tumors.
Treatment Innovation
The investigator explores comparative therapeutic approaches in oncology, evaluating both established and novel treatment modalities for advanced cancers.
- Growth modulation assessment
- Progression-free survival studies
- Combination therapy evaluation
Their research encompasses systematic evaluation of therapeutic efficacy in advanced cancer treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.